AVXL Operating Cash Flow Growth
Anavex Life Sciences Corp · Operating Cash Flow Growth
AVXL Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported9.08%period ending
AVXL TTM Cash from Operations YoY % (46.90% → 9.08%)
Year-over-year change
High-resolution chart · PNG
AVXL operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 9.076% | |
| -9.5425% | |
| 4.3213% | |
| -26.7169% | |
| -23.645% | |
| 8.1986% | |
| -21.5096% | |
| -10.8919% | |
| -15.4877% | |
| -27.9594% | |
| -10.4735% | |
| -14.6373% | |
| 6.7765% | |
| 10.4301% | |
| -1.99% | |
| 20.2273% | |
| 3.7823% | |
| -11.1769% | |
| -11.0099% | |
| -42.7332% | |
| -64.8809% | |
| -21.2318% | |
| -16.6292% | |
| -14.8967% | |
| 12.3686% | |
| -43.6728% | |
| -53.1126% | |
| -47.2462% | |
| -86.9766% | |
| -26.0703% | |
| -38.3678% | |
| -39.5374% | |
| -23.3927% | |
| -46.2121% | |
| -3.7238% | |
| 2.3774% | |
| 1.3433% | |
| 0.9355% | |
| -34.8339% | |
| -118.5193% | |
| -137.351% | |
| -147.3112% | |
| -132.4327% | |
| -58.9471% | |
| -66.612% | |
| -149.3972% | |
| -169.8877% | |
| -242.0102% | |
| -308.6312% | |
| -72.8809% | |
| -46.7959% | |
| 54.0697% | |
| 76.942% | |
| 77.4381% | |
| 80.65% | |
| 55.4663% | |
| 47.9668% | |
| 24.9047% | |
| 22.2956% | |
| 17.2438% | |
| -16.4336% | |
| -11.3426% | |
| -48.1294% | |
| -64.3705% | |
| -50.7611% | |
| -98.7928% | |
| -60.0386% | |
| -12.9586% | |
| -46.2267% | |
| -45.7366% | |
| -107.8542% | |
| -660.662% | |
| -477.5236% | |
| -1,700.0969% | |
| -2,441.9657% | |
| -902.9912% | |
| -2,519.4905% | |
| -96.6963% | |
| 35.9756% | |
| 46.902% |